Latest News and Press Releases

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence" directory has been added to ResearchAndMarkets.com's...

STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the passing of our beloved and longtime Board Member Benson...

60% (12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) EO2463 plus R2 was well tolerated in patients with follicular and marginal zone...

Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of indolent non-Hodgkin lymphoma (iNHL)$9 million from new investor The Institute...

Gift of Life Marrow Registry hosted its One Huge Night NYC Gala, where two lifesaving blood stem cell donors were united with their transplant recipients.

New York, USA, May 12, 2025 (GLOBE NEWSWIRE) -- Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight The blood cancer market...

Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership Allogenica received a €2.5 million grant from the French government's France...

Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Blood Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Assay Kits And Reagents), By Test (Blood Tests,...

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host...

Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics Market Size, Share & Trends Analysis by Product, Test, End Use, and Region, 2025-2030" report has been added to ...